Burch Dental Partners: The Clinician-Owned DSO Bet

Most dental support organizations are built backward from an exit: assemble offices, standardize the back office, and sell the platform to a larger consolidator within a few years. Burch Dental Partners, a clinician-owned group headquartered in Rockford, Illinois, is being built around the opposite premise — that a dentist who never intends to sell can use the DSO toolkit to compound clinical quality and culture rather than cash out. Founded by a periodontist and organized around prevention, it is a small, Midwest-rooted network that is interesting less for its current scale than for what its model says about where doctor-led consolidation is heading.

Overview

Burch Dental Partners (BDP) is a clinically focused, multidisciplinary dental network that has been operating since 2007¹ and supports practices across northern Illinois, Wisconsin, and Florida.² It was founded and is led by Dr. Jeffrey Burch, a periodontist and U.S. Army veteran who continues to serve as the organization's chief executive and, with his partners, owns and operates the group.¹ That ownership posture is the company's headline differentiator: its own materials describe it as "Clinician-Owned, DSO-Supported," and trade coverage frames it as an attempt to "revitalize the notion of what a DSO can be" — a doctor-led alternative the founder half-jokingly calls "DSO 3.0."³

The clinical model follows from the founder's specialty. BDP is hygiene-centric and prevention-first, combining periodontics, pediatrics, and general dentistry under a philosophy of treating periodontal disease at its earliest stages rather than waiting for surgical need.¹ Hygienists are positioned not just as clinical staff but as participants in office management and leadership, and the group reports treating patients "from birth to death" — a recurring-revenue, lifetime-relationship orientation that maps neatly onto the economics of recall-driven preventive care.¹ Culture is codified in an acronym, C.H.E.W. (Commitment to excellence, Humble and hungry, Effective communication, Winning attitude), that the company says it uses for hiring, recognition, and operational decisions.¹

For an investor, the relevant frame is that BDP is an early-stage, regional platform whose value proposition is qualitative — clinician alignment, retention, and preventive-care quality — more than it is scale. The numbers it does publicize tend to be operational quality metrics rather than financials, and several structural details (exact entity-level practice count, unit economics, technology stack) are not publicly disclosed. The sections below separate what is reasonably well established from what should be treated as company-reported or unverified.

Company Snapshot

• Headquarters: Rockford, Illinois (Winnebago County, northern Illinois near the Wisconsin border)³
• Founder & CEO: Dr. Jeffrey Burch, periodontist and U.S. Army veteran¹
• Operating since: 2007¹
• Model: Clinician-owned, doctor-led dental support organization; affiliations plus de novo (ground-up) development²
• Clinical focus: Multidisciplinary — periodontics, pediatrics, and general dentistry; hygiene-centric, prevention-first¹
• Footprint (latest): Reached its 16th affiliate practice — its 7th de novo — as reported in early 2026; a separate 2026 profile put it at roughly 15 practices across Illinois, Florida, and Wisconsin²
• Geography: Illinois (Rockford-area core, including Machesney Park), with locations in Wisconsin and Florida²
• Patient-facing brand: "Burch Dental" in the greater Rockford market, distinct from the "Burch Dental Partners" support entity³
• Recognition: Named an "Emerging Dental Group to Watch in 2026"; cited among fast-growing private companies in industry rankings²
• Ownership/capital: Doctor-owned and self-financed (founder equity plus bank financing); described in trade coverage as not private-equity-backed, with a stated long-term plan to build an internal, doctor-funded capital platform rather than take outside investment²

Footprint Analysis

BDP's footprint should be read carefully, because the public figures count different things at different moments. The most recent and most specific datapoints come from Group Dentistry Now's 2026 coverage, which reported that the group had reached its sixteenth affiliate practice — its seventh de novo — and a 2026 profile that put it at roughly fifteen practices across Illinois, Florida, and Wisconsin.² An earlier, undated industry profile described a smaller network of "12 locations in Illinois, one in Wisconsin."¹ The honest reading is that the group has grown from roughly a dozen-plus locations to the mid-teens over the period spanned by those sources — but "affiliate practices," "offices," and the consumer-facing "Burch Dental" locations are not necessarily the same denominator, so any precise headcount should be hedged.

Geographically, the network's center of gravity is the Rockford metro in northern Illinois, where the patient-facing Burch Dental brand operates multiple offices (including in Machesney Park).³ From that core it has extended across the nearby Wisconsin state line and, more recently, into Florida — so while the Illinois base is tightly clustered, the group has shown it will also plant offices outside a single contiguous region.² The dense-core pattern is operationally sensible for a group this size: it allows shared staffing, centralized administration, and consistent clinical protocols across the Illinois cluster, even as the out-of-state locations test the model in newer markets. The roughly even split between de novo builds (seven of sixteen) and affiliations signals a group comfortable creating supply where it wants control over design and culture, not merely acquiring existing patient panels.²

What the footprint data does not tell us is just as important. There is no public, audited count of operatories, providers, or revenue. A figure of "fifteen practices and twenty-three dentists" has been stated by the founder in interviews, but that is a self-reported, point-in-time number and should be treated as indicative rather than precise.¹ For diligence purposes, BDP is best characterized as a mid-double-digit-location (mid-teens) regional platform still early in its scaling curve.

Growth History

BDP's arc runs from a single-market Rockford practice into a regional, multi-disciplinary network over roughly fifteen-plus years of operation since 2007.¹ The early expansion appears to have been organic and partner-driven rather than sponsor-fueled: trade coverage describes Dr. Burch and his partners owning and operating the practices, and the group's growth through affiliations and ground-up builds is consistent with a self-funded regional roll-up rather than an aggressive, sponsor-backed acquisition spree.¹

A distinctive — and, for investors, double-edged — feature of that history is the founder's willingness to subordinate growth to culture fit. In one widely cited example, Dr. Burch described closing and selling an office "for an 80% discount" because a partner's values did not align with the organization, absorbing a deliberate loss rather than retaining a misaligned practice.¹ The same coverage notes the group reinvesting in compensation — a new full healthcare plan, expanded paid time off, and wage increases intended to lead its local market.¹ These are growth choices oriented around retention and clinical consistency, which the company argues ultimately protect quality metrics such as its reported patient reappointment rates (a company-stated 99% on the periodontal side against a cited 91% industry norm).¹

The question of outside capital has a clear answer in the group's own telling. Burch Dental Partners describes itself as self-financed — funded primarily through its founder's equity alongside bank financing — and explicitly not private-equity-backed.² Its stated ambition is to build an internal, doctor-funded capital platform over a long, multi-decade horizon, deferring any consideration of outside institutional investment until the group reaches a far larger revenue scale.² Its recognition as an "Emerging Dental Group to Watch in 2026" reflects momentum and visibility, not a financing event.² For an investor, the practical implication is that BDP is not a sponsor-backed roll-up today and, on its own account, is not courting one — a posture consistent with its "never sell" positioning but also one that caps the pace at which it can scale.

Competitive Landscape

BDP operates at the small, early end of a consolidation spectrum anchored by national platforms many multiples its size. Heartland Dental, the largest U.S. DSO, and PDS Health, which supports more than a thousand offices across two dozen states, define the scale tier BDP is explicitly not competing in; in the very same 2026 deal coverage that noted BDP's sixteenth practice, those groups were opening de novos by the handful.² BDP's relevance is not as a scale competitor but as an example of a clinician-led model positioned against the large-platform default.

The most useful structural analog is MB2 Dental, which built its growth around a doctor-ownership-and-partnership model rather than full buyouts — a closer philosophical cousin to BDP's "clinician-owned, DSO-supported" framing than the more centralized national chains.² Where MB2 has scaled that partnership model nationally, BDP applies a similar alignment thesis at regional density, leaning on its periodontist founder's prevention-first clinical identity as differentiation. Among Midwest-oriented groups, Great Expressions Dental Centers illustrates the more conventional, operations-led regional DSO against which BDP positions its "DSO 3.0" pitch.

Competitively, BDP's moat is narrow but real for its niche: it markets itself to dentists who are "softening to the idea" of a DSO but remain wary of selling out, using clinical autonomy, a prevention philosophy, and a stay-and-grow culture as recruiting tools — its founder's blunt formulation is that "the only way to beat a DSO is with a DSO."¹ The risk is the mirror image of that strength. A small, founder-centric, culture-gated group is harder to scale quickly, more dependent on a single clinical leader, and competing for affiliation targets against far better-capitalized buyers. Whether deliberate cultural selectivity is a durable advantage or a growth ceiling is the central open question.

Market Position

For investors evaluating the doctor-led DSO thesis, BDP is a clean, small-scale expression of it: clinician ownership, prevention-centric clinical economics, and culture treated as an operating system rather than a slogan. It sits in the increasingly active "emerging group" tier of the dental market — too established to be a startup, too small to be a platform — where the strategic question is whether such groups become acquisition targets, regional consolidators in their own right, or durable independents. BDP's stated "never sell" ethos and de novo capability suggest it is aiming for the latter two, but its modest scale and undisclosed financials mean that conviction here rests largely on the founder's track record and the credibility of its quality metrics.

The realistic near-term position is that of a high-conviction, low-liquidity regional story. The preventive, hygiene-led model produces the kind of recurring, recall-driven revenue institutional buyers like, and the clinician-alignment narrative is genuinely countercyclical to consolidation fatigue among selling dentists. Against that, its self-financed, non-institutional capital base, the dependence on one clinical founder, and the deliberate trade-off of growth for culture fit all cap how fast and how large this can scale on its current footing. BDP is best understood today as a credible proof point for the doctor-led model in the Midwest — worth tracking precisely because its trajectory will help answer whether prevention-first, clinician-owned groups can compound without surrendering to the larger platforms they were built to resist.

TMR Take: For operators: BDP is a useful template for the clinician-owned, prevention-first model — density before geography, hygiene leadership embedded in management, and culture used as an explicit hiring and retention filter. Note the discipline trade-off: the willingness to divest a misaligned office at a deep loss is a real strategy, not a slogan, and it caps growth speed. For vendors: This is a small, founder-led buyer that values clinical autonomy and prevention; expect technology and product decisions to flow through the founder and a tight central team, with adoption pitched on clinical quality and patient experience rather than enterprise procurement. For investors: Treat BDP as an early-stage regional platform, not a scaled asset — roughly 15 to 16 locations, doctor-owned and self-financed (described as not PE-backed), with strong qualitative signals (retention, reappointment rates) but undisclosed financials. The thesis to underwrite is whether a "never sell," culture-gated model can compound; the key diligence items are entity-level location and provider counts, true revenue and margin, and whether the internal, doctor-funded capital plan can fund the next leg of growth.

Sources

1. DEO (Dentist Entrepreneur Organization) — "Emerging Groups to Watch" profile of Burch Dental Partners, including founder interview.

2. Group Dentistry Now — DSO industry deal coverage and "Emerging Dental Groups to Watch in 2026" reporting.

3. Burch Dental Partners — company website and public-facing materials.